Barclays
STIM icon

Barclays’s Neuronetics STIM Stock Holding History

Barclays’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.43K Sell
6,504
-55,102
-89% -$87.3K ﹤0.01% 4709
2025
Q4 		$85K Buy
61,606
+9,941
+19% +$20.8K ﹤0.01% 4623
2025
Q3 		$141K Sell
51,665
-11,715
-18% -$41.6K ﹤0.01% 4513
2025
Q2 		$221K Buy
+63,380
New +$250K ﹤0.01% 4210
2022
Q3 		– Sell
-94
Closed – – 5124
2022
Q2 		$0 Sell
94
-4,051
-98% -$11.8K ﹤0.01% 5252
2022
Q1 		$12K Sell
4,145
-26,827
-87% -$90.7K ﹤0.01% 4568
2021
Q4 		$138K Buy
30,972
+20,543
+197% +$101K ﹤0.01% 3661
2021
Q3 		$69K Buy
10,429
+7,270
+230% +$69.7K ﹤0.01% 4031
2021
Q2 		$51K Sell
3,159
-1,939
-38% -$26.8K ﹤0.01% 4127
2021
Q1 		$63K Sell
5,098
-5,758
-53% -$88.3K ﹤0.01% 4156
2020
Q4 		$121K Sell
10,856
-11,723
-52% -$88.1K ﹤0.01% 4049
2020
Q3 		$110K Sell
22,579
-3,819
-14% -$14.5K ﹤0.01% 4202
2020
Q2 		$51K Buy
26,398
+21,939
+492% +$45K ﹤0.01% 4928
2020
Q1 		$9K Sell
4,459
-8,979
-67% -$28.1K ﹤0.01% 5850
2019
Q4 		$60K Buy
13,438
+6,646
+98% +$41.3K ﹤0.01% 5687
2019
Q3 		$57K Sell
6,792
-1,890
-22% -$20.6K ﹤0.01% 5850
2019
Q2 		$109K Buy
8,682
+2,543
+41% +$35.9K ﹤0.01% 5618
2019
Q1 		$94K Buy
6,139
+4,839
+372% +$80.1K ﹤0.01% 5410
2018
Q4 		$25K Sell
1,300
-1,091
-46% -$23.9K ﹤0.01% 5798
2018
Q3 		$77K Buy
+2,391
New +$72.7K ﹤0.01% 5788

Other funds holding STIM

MAM
Madryn Asset Management New York $34.1M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Barclays's STIM Position: Q1 2026 in Review

Barclays reduced its Neuronetics (STIM) stake by 89% in Q1 2026, selling an estimated $87.3K and leaving 6,504 shares worth $9.43K. The position accounts for ﹤0.01% of the portfolio, ranked #4709.

Barclays first reported a position in STIM in Q3 2018 and has held it in 20 quarters since. The position peaked at $221K in Q2 2025. 99 funds tracked by Wall St. Rank hold STIM as of Q1 2026.

  • Barclays held 6,504 shares of Neuronetics worth $9.43K as of Q1 2026.
  • Barclays sold 55,102 Neuronetics shares in Q1 2026, an estimated $87.3K.
  • Neuronetics made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4709 holding.
  • Barclays first reported a position in Neuronetics in Q3 2018 and has held it in 20 quarters since.
  • Barclays's Neuronetics position peaked at $221K in Q2 2025.
  • 99 funds tracked by Wall St. Rank held Neuronetics as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.